» Authors » Bojana B Beleslin-Cokic

Bojana B Beleslin-Cokic

Explore the profile of Bojana B Beleslin-Cokic including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 377
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Damjanovic S, Antic J, Elezovic-Kovacevic V, Dundjerovic D, Milicevic I, Beleslin-Cokic B, et al.
J Clin Endocrinol Metab . 2020 Sep; 105(12). PMID: 32901291
Context: Adrenal lesions are frequent among patients with sporadic neuroendocrine tumors (spNETs) or multiple endocrine neoplasia type 1 (MEN1). Armadillo repeat-containing 5 (ARMC5)-inactivating variants cause adrenal tumors and possibly other...
2.
Suboticki T, Ajtic O, Beleslin-Cokic B, Bjelica S, Djikic D, Diklic M, et al.
Cell Biol Int . 2018 Dec; 43(2):192-206. PMID: 30571852
Myeloproliferative neoplasms (MPNs) are developing resistance to therapy by JAK1/2 inhibitor ruxolitinib. To explore the mechanism of ruxolitinib's limited effect, we examined the JAK1/2 mediated induction of proliferation related ERK1/2...
3.
Suboticki T, Ajtic O, Beleslin-Cokic B, Nienhold R, Diklic M, Djikic D, et al.
Mol Carcinog . 2016 Jun; 56(2):567-579. PMID: 27341002
It has been shown that angiogenesis and inflammation play an important role in development of most hematological malignancies including the myeloproliferative neoplasm (MPN). The aim of this study was to...
4.
cokic V, Mitrovic-Ajtic O, Beleslin-Cokic B, Markovic D, Buac M, Diklic M, et al.
Mediators Inflamm . 2015 Oct; 2015:453020. PMID: 26491227
The recent JAK1/2 inhibitor trial in myeloproliferative neoplasms (MPNs) showed that reducing inflammation can be more beneficial than targeting gene mutants. We evaluated the proinflammatory IL-6 cytokine and JAK-STAT signaling...
5.
cokic V, Mossuz P, Han J, Socoro N, Beleslin-Cokic B, Mitrovic O, et al.
PLoS One . 2015 Aug; 10(8):e0135463. PMID: 26275051
The gene and protein expression profiles in myeloproliferative neoplasms (MPNs) may reveal gene and protein markers of a potential clinical relevance in diagnosis, treatment and prediction of response to therapy....
6.
cokic V, Diklic M, Suboticki T, Beleslin-Cokic B, Markovic D, Milenkovic P, et al.
J BUON . 2014 Mar; 19(1):304-14. PMID: 24659680
Purpose: The purpose of this study was to examine the gene expression profile of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood (mPB)-derived progenitors, used in transplantation. Methods: We correlated gene...
7.
cokic V, Bhattacharya B, Beleslin-Cokic B, Noguchi C, Puri R, Schechter A
J Transl Med . 2012 Jun; 10:116. PMID: 22676255
Background: It has been reported that the phosphatidylinositol 3-kinase (PI3K)-AKT signaling pathway regulates erythropoietin (EPO)-induced survival, proliferation, and maturation of early erythroid progenitors. Erythroid cell proliferation and survival have also...
8.
Gojkovic-Bukarica L, Beleslin-Cokic B, Novakovic A, Peric M, Markovic-Lipkovski J, Cirovic S, et al.
J Cardiovasc Pharmacol . 2011 Feb; 57(6):648-55. PMID: 21346595
Because adrenergic contractions can contribute to the development of life-threatening spasm of coronary artery bypass graft, this study was performed to investigate the effect of adenosine 3-phosphate (ATP)-sensitive K channel...
9.
Beleslin-Cokic B, cokic V, Wang L, Piknova B, Teng R, Schechter A, et al.
Cytokine . 2011 Feb; 54(2):129-35. PMID: 21324713
Acute lung exposure to low oxygen results in pulmonary vasoconstriction and redistribution of blood flow. We used human microvascular endothelial cells from lung (HMVEC-L) to study the acute response to...
10.
cokic V, Beleslin-Cokic B, Smith R, Economou A, Wahl L, Noguchi C, et al.
Exp Hematol . 2009 Jul; 37(10):1230-7. PMID: 19576950
Objective: We have previously shown that nitric oxide (NO) is involved in the hydroxyurea-induced increase of gamma-globin gene expression in cultured human erythroid progenitor cells and that hydroxyurea increases NO...